Bracco MultiHance "approvable"
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Bracco Diagnostics' injectable magnetic resonance imaging agent MultiHance (gadobenate dimeglumine) is "approvable" at FDA for central nervous system imaging, the firm announces Nov. 25. Bracco is highlighting higher image quality due to the gadolinium contrast agent's increased relaxivity. MultiHance is approved in the EU for CNS and liver imagin